At 5 years, the linear model for RMST differences found that factors associated with better OS included younger age, lower AFP level, higher platelet counts, lower total bilirubin level, no cirrhosis, solitary tumor, tumor encapsulation, smaller tumor, better than grade 1 MVI, better than grade 2, and using tenofovir disoproxil (eTable 2 in Supplement 1). Here, AFP is linked to Cirrhosis.